Pharmadeal Private Limited
About Pharmadeal Private Limited
Data last updated:
Pharmadeal Private Limited is a private limited company based in Jabalpur, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 January 1978 and has been in existence for over 48 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U02423MP1978PTC001431. Its GSTIN is 23AACCP5577C1ZL (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.91 Lakh. It is led by directors Rahul Kothari and Nitin Tiwari.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 01 Kumar Complex Gorakhpur, Jabalpur, Madhya Pradesh, India – 482001.
As per the financials filed for FY 2021, the company reported a revenue of ₹81.64 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹68.36 Lakh (net margin 83.7%) and EBITDA of ₹75.36 Lakh (EBITDA margin 92.3%). Revenue has grown at a compounded annual rate (CAGR) of 350% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Pharmadeal Private Limited's registered office is in Jabalpur, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address01 Kumar Complex Gorakhpur, Jabalpur, Madhya Pradesh, India – 482001
- IndustryPharma, Drug Formulation & Development, Pharmaceutical Retailers & Distributors
To see the full contact details of Pharmadeal Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Pharmadeal Private Limited
FY 2021 filings availablePharmadeal Private Limited reported revenue of ₹81.64 Lakh (up 213% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 350% over five years, including 213% growth in the latest year. EBITDA rose 242% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹75.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹68.36 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 92.3% | ||||
| Net Profit Margin | 83.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharmadeal Private Limited, buy the company report.
Board of directors of Pharmadeal Private Limited
Pharmadeal has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Kothari | Director | 11 Apr 2019 | 7 Years 6 Months | Current |
| Nitin Tiwari Also directs: Signature Infraventures LLP, Rayns Mining Private Limited, Shoonya Mobility Private Limited and 4 more | Director | 04 Jun 2020 | 6 Years 4 Months | Current |
Peer comparison
Pharmadeal Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Curofy Pharmaceuticals Private Limited | ₹81.82 Lakh (FY 2025) | -16.0% | Bangalore, Karnataka, India | |||
| Gracia Lifesciences India Private Limited | ₹81.81 Lakh (FY 2025) | Chandigarh, India | ||||
| Inframed Lifesciences Private Limited | ₹81.77 Lakh (FY 2025) | 77.0% | Pune, Maharashtra, India | |||
| Ximing Labs Private Limited | ₹81.75 Lakh (FY 2024) | 32.0% | Palanpur, Gujarat, India | |||
| Kirat Lifesciences Private Limited | ₹81.69 Lakh (FY 2024) | -36.0% | Delhi, India | |||
| Pharmadeal Private Limitedthis company | ₹81.64 Lakh (FY 2021) | ₹68.36 Lakh | 83.7% | 213.0% | Jabalpur, Madhya Pradesh, India | |
| Nayan Pharmaceuticals Limited | ₹81.6 Lakh (FY 2024) | 16.0% | Punjab, India | |||
| Hindustan Bio Sciences Limited | ₹81.32 Lakh (FY 2025) | -23.0% | Hyderabad, Telangana, India | |||
| Lifeways Formulations Private Limited | ₹81.31 Lakh (FY 2025) | -12.0% | Delhi, India | |||
| Sens Chemical Works Pvt Ltd | ₹81.27 Lakh (FY 2025) | -5.0% | Kolkata, West Bengal, India | |||
| Medzone Pharmaceuticals Private Limited | ₹81.23 Lakh (FY 2024) | -24.0% | Puducherry, India |
To see the full peer comparison of Pharmadeal Private Limited, buy the company report.
Auditor
Pharmadeal Private Limited is audited by P C BERDIA & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P C BERDIA & CO | FY 2019 | 000422C |
Shareholding
The shareholding of Pharmadeal Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Pharmadeal Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pharmadeal Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmadeal Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pharmadeal has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCP5577C1ZL | Madhya Pradesh | Active | 22 Jul 2020 |
To see the full GST registrations and return filing status of Pharmadeal Private Limited, buy the company report.
Recent activity
Pharmadeal Private Limited has 7 board changes on record since 2013: 2 appointments and 5 cessations. The latest: Aniruddh Singh ceased to be Director on 04 Jun 2020.
Frequently asked questions
Pharmadeal is an active private limited company based in Jabalpur, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 January 1978 (48+ years old) and is registered under CIN U02423MP1978PTC001431.
Pharmadeal has 2 current directors:
- Rahul Kothari - Director
- Nitin Tiwari - Director
The latest financial statements of Pharmadeal on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Pharmadeal is 23AACCP5577C1ZL, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Pharmadeal is U02423MP1978PTC001431. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmadeal was incorporated on 03 January 1978, making it 48+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Pharmadeal by revenue are Curofy Pharmaceuticals Private Limited, Gracia Lifesciences India Private Limited, Inframed Lifesciences Private Limited, Ximing Labs Private Limited, Kirat Lifesciences Private Limited and 5 more, all in the Pharma industry (Formulations, Pharma Retail and Distribution).
Aniruddh Singh ceased to be Director on 04 Jun 2020. Nitin Tiwari was appointed as Director on 04 Jun 2020. Abha Lunia ceased to be Director on 27 May 2019. Pharmadeal has 7 board changes on record in total.
The registered office of Pharmadeal is at 01 Kumar Complex Gorakhpur, Jabalpur, Madhya Pradesh, India – 482001.
Pharmadeal operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Pharmadeal is compliant as of 11 August 2026. The company is actively filing with the Registrar of Companies.